Descriptiontest
OEP000983
Description
OEP003026
DescriptionIgA nephropathy (IgAN) is a major cause of kidney failure worldwide. Here we investigated the contribution of genome-wide protein coding variants to IgAN risk by performing a three-stage exome chip-based association study in 8,529 IgAN patients and 23,224 healthy controls of Han Chinese ancestry. We discovered a novel rare nonsynonymous risk variant in VEGFA, and further sequencing of VEGFA revealed twice as many carriers of other rare variants in 2,148 IgAN cases compared to 2,732 controls. We also discovered a common nonsynonymous risk variant in PKD1L3, and the variant was shown to be associated with nearby HP gene expression and lower protein level by previous and current studies. However, a common loss-of-function mutation of PKD1L3 did not show any association, suggesting that HP is more likely to be a susceptibility gene for IgAN. Our discovery of VEGFA and HP has expanded understanding on the genetic basis of IgAN susceptibility.
OEP003779
DescriptionTo explore microenvironmental alterations in liver cancer, parenchymal and stromal tissues were extracted via laser-capture microdissection from tumors and corresponding adjacent non-tumor areas within 6 HCC patients with rich stromal components. To we divided the parenchymal region (T-P and N-P) and the stromal region (T-S and N‒S) according to locations and tissue morphology in the tumor and adjacent non-tumor area. Formalin-fixed paraffin-embedded sections were thus obtained for proteomic analysis utilizing data-independent collection (DIA) mass spectrometry (MS).
OEP004595
Description
OEP003685
DescriptionHere, we performed single-cell RNA sequencing of pre-treatment tumor samples in 26 patients with early-stage TNBC and 6 patients with advanced TNBC to define anti-PD-1 response-related components in the tumor microenvironment. Also, we performed RNA sequencing of pre-treatment tumor samples in 60 patients with early-stage TNBC receiving neoadjuvant anti-PD1 treatment.
OEP003394
Description
OEP002590
DescriptionThe dataset contains mRNA expression (TPM) of 32 stage IV NSCLC patients (including LUAD and LUSC)
OEP004524
DescriptionNitrate-mediated sulfur-oxidizing communities
OEP004208
Description
OEP001143